Loading...
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations
With advancement of technologies such as genomic sequencing, predictive biomarkers have become a useful tool for the development of personalized medicine. Predictive biomarkers can be used to select subsets of patients, which are most likely to benefit from a treatment. A number of approaches for su...
Na minha lista:
| Udgivet i: | Pharm Stat |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6772173/ https://ncbi.nlm.nih.gov/pubmed/31270933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1951 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|